The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses

Alejandra Castanon, Rebolj M Matejka, Francesca Pesola, Peter Sasieni
doi: https://doi.org/10.1101/2020.11.30.20240754

Article usage

Article usage: November 2020 to July 2025

AbstractFullPdf
Nov 2020221035
Dec 202093246147
Jan 20212605476
Feb 20211657746
Mar 20211157667
Apr 20211135638
May 20211138443
Jun 2021735332
Jul 2021734326
Aug 2021553839
Sep 2021583239
Oct 2021592335
Nov 2021551732
Dec 2021471017
Jan 2022572030
Feb 2022571028
Mar 2022581222
Apr 20224575
May 2022531512
Jun 20223185
Jul 20222925
Aug 20222546
Sep 202241310
Oct 202253210
Nov 202231710
Dec 202236713
Jan 202334911
Feb 20231939
Mar 20233233
Apr 20233648
May 202322711
Jun 20232559
Jul 20232025
Aug 2023272112
Sep 202323159
Oct 2023231016
Nov 202330710
Dec 202320717
Jan 202416212
Feb 202425621
Mar 202411419
Apr 202420819
May 202421217
Jun 202421520
Jul 202410223
Aug 202436626
Sep 202429820
Oct 2024151131
Nov 202426936
Dec 202412322
Jan 202513526
Feb 202592031
Mar 2025533138
Apr 202523931
May 2025141633
Jun 2025291630
Jul 202510715
Back to top
Posted November 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email
The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses
Alejandra Castanon, Rebolj M Matejka, Francesca Pesola, Peter Sasieni
medRxiv 2020.11.30.20240754; doi: https://doi.org/10.1101/2020.11.30.20240754
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area